STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Jan. 31, 2020

Equity [Abstract]

Schedule of nonvested share activity

	Number of shares awarded total
	Minimum		Target		Maximum		Cap
Employees		17,834		26,753		35,670		42,805
Non-Employee Directors		7,168		10,752		14,336		17,204
Total		25,002		37,505		50,006		60,009

	Value at grant date (numbers below are rounded to the nearest 100)
	Minimum		Target		Maximum		Cap
Employees	$	248,800	$	373,200	$	497,600	$	597,120
Non-Employee Directors		100,000		150,000		200,000		240,000
Total	$	348,800	$	523,200	$	697,600	$	837,120

Schedule of share-based compensation

	Number of shares awarded total
	Minimum		Target		Maximum
Employees		48,186		74,133		88,960
Non-Employee Directors		16,360		25,168		30,204
Total		64,546		99,301		119,164

	Value at grant date (numbers below are rounded to the nearest $100)
	Minimum		Target		Maximum
Employees	$	497,800	$	765,800	$	918,960
Non-Employee Directors		169,000		260,000		312,000
Total	$	666,800	$	1,025,800	$	1,230,960

Schedule of restricted stock units award activity

	Year Ended January 31,
	2020			2019
2017 Plan:
Restricted Stock Program	$	(443,441	)	$	721,111
Stock Options		27,577			-----
Cash-based Bonus		38,677			-----
	$	(377,187	)	$	721,111
Stock appreciation rights	$	(25,559	)	$	22,646
Total stock-based compensation	$	(402,746	)	$	743,757
Total income tax benefit (expense) recognized for stock-based compensation arrangements	$	(85,577	)	$	267,752

Schedule of stock option activity

Shares issued under 2017	Outstanding Unvested Grants at Maximum at Beginning of FY20		Granted during FY20		Becoming Vested during FY20		Forfeited during FY20		Outstanding Unvested Grants at Maximum at End of January 31, FY20
Restricted stock grants – employees		84,126		-----		-----		48,456		35,670
Restricted stock grants – non-employee directors		28,829		-----		-----		14,493		14,336
Retainer in stock – non-employee directors		25,044		7,292		7,568		----		24,768
Total restricted stock		137,999		7,292		7,568		62,949		74,774
Weighted average grant date fair value		13.77		10.44		14.72		13.82		11.53

Stock Options	Number of Shares		Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value
Outstanding at January 31, 2019		-----	$	-----		-----	$	-----
Granted		24,900	$	11.17		-----		-----
Outstanding at January 31, 2020		24,900	$	11.17		9.53		-----
Exercisable at January 31, 2020		-----	$	-----		-----	$	-----

Assumptions used to calculate the fair value of the options granted

	FY20
Expected volatility		53	%
Expected life in years		10
Expected dividend yield		0.00	%
Risk-free interest rate		1.65	%